510(k) device
FreeStyle Libre 2 Flash Glucose Monitoring System
Abbott Diabetes Care, Inc. · Integrated Continuous Glucose Monitoring System, Factory Calibrated (QBJ, Class II) · First FDA decision Mar 3, 2023, newest Mar 3, 2023Diabetes
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
118
Naming "FreeStyle Libre 2"
MAUDE reports
237,977
Brand "FreeStyle Libre 2", since 2015
PubMed studies
108
Mentioning "FreeStyle Libre 2"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing FreeStyle Libre 2 Flash Glucose Monitoring System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K222447 · Decided Mar 3, 2023 · 200 days after receipt
Device type: Integrated Continuous Glucose Monitoring System, Factory Calibrated (QBJ) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Implantable Continuous Glucose Monitors (I-CGM)Local determinationIn effectL38662CGS Administrators, LLCUpdated Sep 29, 2026
- Implantable Continuous Glucose Monitors (I-CGM)Local determinationIn effectL38623Wellpoint FederalUpdated Jul 14, 2026
- Implantable Continuous Glucose Monitors (I-CGM)Local determinationIn effectL38686WPS Insurance CorporationUpdated Jun 18, 2026
- Implantable Continuous Glucose Monitors (I-CGM)Local determinationIn effectL38657Noridian Healthcare Solutions, LLCUpdated Oct 14, 2025
- Home Health Plans of Care: Monitoring Glucose Control in the Medicare Home Health Population with Type II Diabetes MellitusLocal determinationIn effectL35132Palmetto GBAUpdated Apr 9, 2025
- Implantable Continuous Glucose Monitors (I-CGM)Local determinationIn effectL38743Palmetto GBAUpdated Jul 19, 2024
- Implantable Continuous Glucose Monitors (I-CGM)Local determinationIn effectL38664First Coast Service Options, Inc.Updated Jun 21, 2024
- Implantable Continuous Glucose Monitors (I-CGM)Local determinationIn effectL38617Novitas Solutions, Inc.Updated Jun 21, 2024
Clinical trials
Device studies on ClinicalTrials.gov that name "FreeStyle Libre 2", any status and sponsor, newest update first.
- Transition to Hospital Discharge in Insulinized Patients With Type 2 Diabetes MellitusActive, not recruiting
Instituto de Investigacion Sanitaria La FeAcademic, hospital or other
NCT07061301 · 80 participants (planned) · Start Aug 1, 2024 · Primary completion Oct 8, 2026
Device: Usual Care group; Technological group · For: Type 2 Diabetes Mellitus (T2DM); Continuous Glucose Monitoring; CGM and 2 more
Sites: Valencia, Spain
- Glucose Pattern in Infertile Women Receiving Assisted Reproduction Using Continuous Glucose MonitoringActive, not recruiting
Shanghai 6th People's HospitalAcademic, hospital or other
NCT06863337 · 100 participants (planned) · Start Mar 26, 2025 · Primary completion Jun 30, 2026
Device: CGM · For: Infertility Female
Sites: Shanghai, China
- Comparison of Dietetics Support With and Without Continuous Glucose Monitoring in Individuals With Type 2 Diabetes.Pivotal-lookingActive, not recruiting
Australian Catholic UniversityAcademic, hospital or other
NCT06888687 · 160 participants · Start May 12, 2025 · Primary completion Nov 28, 2026
Device: Continuous glucose monitoring · For: Type 2 Diabetes Mellitus (T2DM); Continuous Glucose Measurement; Dietary Modification
Sites: Melbourne, Australia
115 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "FreeStyle Libre 2", and for the whole product code for context.
This brand
237,977 reports: 196,378 malfunction, 41,515 injury, 51 death
Whole product code QBJ
2,390,871 reports: 2,344,654 malfunction, 45,370 injury, 256 death
Newest reports for this brand
- FreeStyle Libre 2 PlusInjury
2954323-2026-448742 · Received Oct 30, 2026 · Event dated Oct 5, 2026
Device type: Integrated Continuous Glucose Monitoring System, Factory Calibrated (QBJ)
Device problem as coded: High Readings
Patient problem as coded: Hyperglycemia
- FreeStyle Libre 2 PlusMalfunction
2954323-2026-448750 · Received Oct 30, 2026 · Event dated Oct 15, 2026
Device type: Integrated Continuous Glucose Monitoring System, Factory Calibrated (QBJ)
Device problem as coded: Detachment of Device or Device Component
Patient problem as coded: Device Embedded In Tissue or Plaque
- FreeStyle Libre 2 PlusInjury
2954323-2026-448749 · Received Oct 30, 2026 · Event dated Oct 15, 2026
Device type: Integrated Continuous Glucose Monitoring System, Factory Calibrated (QBJ)
Device problem as coded: Unable to Obtain Readings; Device Displays Incorrect Message
Patient problem as coded: Shaking/Tremors; Convulsion/Seizure
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "FreeStyle Libre 2"[tiab]. The summary above synthesizes these.
- HUPA-UCM diabetes dataset.
Hidalgo JI, Alvarado J, Botella M, et al. · Data Brief · 2024
- Freestyle libre 2: The new isobornyl acrylate free generation.
Oppel E, Kamann S, Heinemann L, et al. · Contact Dermatitis · 2020
- Assessment of the FreeStyle Libre 2 interstitial glucose monitor in hypo- and euglycemic cats.
Berg AS, Crews CD, Adin C, et al. · J Vet Intern Med · 2023
- Cost Analysis of FreeStyle Libre® 2 System in Type 2 Diabetes Mellitus Population.
Oyagüez I, Gómez-Peralta F, Artola S, et al. · Diabetes Ther · 2021
- Effectiveness of the freestyle libre 2 flash glucose monitoring system on diabetes-self-management practices and glycemic parameters among patients with type 1 diabetes using insulin pump.
Al Hayek AA, Robert AA, Al Dawish MA · Diabetes Metab Syndr · 2021Clinical Trial
- Effects of 12-Week Freestyle Libre 2.0 in Children with Type 1 Diabetes and Elevated HbA1c: A Multicenter Randomized Controlled Trial.
Jefferies CA, Boucsein A, Styles SE, et al. · Diabetes Technol Ther · 2023Randomized Controlled Trial, Multicenter Study
- Impact of the FreeStyle Libre 2® System on Glycaemic Outcomes in Patients with Type 1 Diabetes-Preliminary Study.
Rutkowska K, oś-Stegienta A, Bagiski M, et al. · Diagnostics (Basel) · 2024
- Analytical Performance of the FreeStyle Libre 2 Glucose Sensor in Healthy Male Adults.
Fellinger E, Brandt T, Creutzburg J, et al. · Sensors (Basel) · 2024
- The FreeStyle Libre 2 system demonstrates limited analytical accuracy without resulting in detrimental clinical decisions.
Herman JL, Lidbury JA, Atiee GF, et al. · Am J Vet Res · 2025
- Evaluation of the Accuracy of FreeStyle Libre 2 for Glucose Monitoring in White New Zealand Rabbits.
Choi M, Chae Y, Park J, et al. · Vet Med Sci · 2025Evaluation Study, Research Support, Non-U.S. Gov't
- A comparison of FreeStyle Libre 2 to self-monitoring of blood glucose in children with type 1 diabetes and sub-optimal glycaemic control: a 12-week randomised controlled trial protocol.
Styles S, Wheeler B, Boucsein A, et al. · J Diabetes Metab Disord · 2021
- Accuracy of a 15-day Factory-Calibrated Continuous Glucose Monitoring System With Improved Sensor Design.
Alva S, Bhargava A, Bode B, et al. · J Diabetes Sci Technol · 2026Multicenter Study, Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code QBJ.
- Dexcom G7 Continuous Glucose Monitoring SystemDexcom, Inc. · 510(k) 2026
- Dexcom G6 Continuous Glucose Monitoring (CGM) SystemDexcom, Inc. · De Novo 2023
- FreeStyle Libre 3 Continuous Glucose Monitoring SystemAbbott Diabetes Care, Inc. · 510(k) 2024
- Dexcom G7 15 Day Continuous Glucose Monitoring SystemDexcom, Inc. · 510(k) 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.